Proteomics InternationalLaboratories LtdInvestor Presentation0September 2026ASX: PIQ | ACN: 169 979 971 | Perth, Western AustraliaDisclaimerThis Presentation is provided by Proteomics International Laboratories Ltd (Proteomics International, Proteomics, the Company, ASX: PIQ). This Presentation...
Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
In the deck
Story so far
Earlier from Proteomics International Laboratories
- PromarkerD and PromarkerEso Commercial Rollout Update
- Appendix 4E and Annual Report
- Appendix 4G and Corporate Governance Statement
- Australian patent for PromarkerEndo
- Change in substantial holding
Later from Proteomics International Laboratories
- Notice of AGM Date
- PromarkerEndo Validation and Refinement Complete
- Ignite Investment Summit Presentation
- Proteomics International receives $2.0m in R&D tax incentive
- Notice of Annual General Meeting/Proxy Form
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories